Shiloh
Editor, Senior Moderator
Would be helpful to know what the drug was..
Source: http://www.twincities.com/allheadlines/ci_13647933?nclick_check=1
Waseca / Experimental H1N1 drug didn't save medical exec
By Jeff Hansel
Rochester Post-Bulletin
Updated: 10/27/2009 05:26:53 AM CDT
Mike Milbrath was in the prime of life ? 54 years old ? and had spent months guiding Waseca Medical Center-Mayo Health System as it prepared for pandemic H1N1 influenza.
Milbrath himself was diagnosed with H1N1, commonly referred to as swine flu, on Oct. 20. His medical condition worsened, so health providers obtained an experimental drug that had shown promise in other patients seriously ill with H1N1.
He received the drug Friday, but he died Saturday evening.
"This is a tragic loss, first for the Milbrath family, but also for the medical community," said Kevin Burns, chief communications officer for Immanuel St. Joseph's-Mayo Health System.
The cause of Milbrath's death hasn't been determined, Burns said.
In the meantime, Milbrath's death might raise awareness about the rare but serious potential for H1N1 complications.
"Part of human nature, perhaps, is until it affects me directly it may not seem as real, or as relevant. All those doubts have been erased," Burns said. Now, he said, all the months of planning, late nights, extended hours and weekend meetings held to plan for H1N1 make sense.
"Now I know why this is so important," he said.
Source: http://www.twincities.com/allheadlines/ci_13647933?nclick_check=1
Waseca / Experimental H1N1 drug didn't save medical exec
By Jeff Hansel
Rochester Post-Bulletin
Updated: 10/27/2009 05:26:53 AM CDT
Mike Milbrath was in the prime of life ? 54 years old ? and had spent months guiding Waseca Medical Center-Mayo Health System as it prepared for pandemic H1N1 influenza.
Milbrath himself was diagnosed with H1N1, commonly referred to as swine flu, on Oct. 20. His medical condition worsened, so health providers obtained an experimental drug that had shown promise in other patients seriously ill with H1N1.
He received the drug Friday, but he died Saturday evening.
"This is a tragic loss, first for the Milbrath family, but also for the medical community," said Kevin Burns, chief communications officer for Immanuel St. Joseph's-Mayo Health System.
The cause of Milbrath's death hasn't been determined, Burns said.
In the meantime, Milbrath's death might raise awareness about the rare but serious potential for H1N1 complications.
"Part of human nature, perhaps, is until it affects me directly it may not seem as real, or as relevant. All those doubts have been erased," Burns said. Now, he said, all the months of planning, late nights, extended hours and weekend meetings held to plan for H1N1 make sense.
"Now I know why this is so important," he said.